Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients

Massimo Tempestilli, Luigia Pucci, Stefania Notari, Antonino Di Caro, Concetta Castilletti, Maria Rosaria Rivelli, Chiara Agrati, Leopoldo Paolo Pucillo

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Ebola virus, an enveloped virus, is the cause of the largest and most complex Ebola virus disease (EVD) outbreak in West Africa. Blood or body fluids of an infected person may represent a biohazard to laboratory workers. Laboratory tests of virus containing specimens should be conducted in referral centres at biosafety level 4, but based on the severity of clinical symptoms, basic laboratories might be required to execute urgent tests for patients suspected of EVD. The aim of this work was to compare the analytical performances of laboratory tests when Triton X-100, a chemical agent able to inactivate other enveloped viruses, was added to specimens. Methods: Results of clinical chemistry, coagulation and haematology parameters on samples before and after the addition of 0.1% (final concentration) of Triton X-100 and 1 h of incubation at room temperature were compared. Results: Overall, results showed very good agreement by all statistical analyses. Triton X-100 at 0.1% did not significantly affect the results for the majority of the analytes tested. Conclusions: Triton X-100 at 0.1% can be used to reduce the biohazard in performing laboratory tests on samples from patients with EVD without affecting clinical decisions.

Original languageEnglish
Pages (from-to)1967-1973
Number of pages7
JournalClinical Chemistry and Laboratory Medicine
Volume53
Issue number12
DOIs
Publication statusPublished - Nov 1 2015

Keywords

  • clinical chemistry
  • coagulation
  • Ebola
  • haematology
  • Triton

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients'. Together they form a unique fingerprint.

Cite this